News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Apex BioStrategists Advises on Flow Cytometry Sale to Beckman Coulter, Inc. (BEC)



5/22/2012 11:46:12 AM

MIAMI, May 22, 2012/PRNewswire-iReach/ -- APEX BIOSTRATEGISTS, A FULL SERVICE ADVISORY FIRM, LED THE TEAM ADVISING THE SELLERS IN THE RECENT ASSET SALE BY NPE SYSTEMS, INC. AND BLUE OCEAN BIOMEDICAL, LLC, BOTH OF PEMBROKE PINES, FLORIDA, TO BECKMAN COULTER. NPE AND BLUE OCEAN WERE TECHNOLOGY LEADERS IN THE FIELD OF FLOW CYTOMETRY WHICH PROVIDES DIAGNOSTIC BLOOD AND TISSUE TESTING FOR PATIENT MONITORING AND FOR DRUG RESEARCH. BECKMAN COULTER IS A MARKET LEADER IN THE SALE OF FLOW CYTOMETRY SYSTEMS TO HOSPITALS AND TESTING LABS THROUGHOUT THE WORLD.

"WE HAVE BEEN ADVISING NPE AND BLUE OCEAN FOR SEVERAL YEARS AS THEY DEVELOPED CUTTING EDGE TECHNOLOGIES AND LICENSED THEM TO MAJOR COMPANIES INCLUDING COULTER AND SONY IN THE PAST.", SAID MARTIN DOYLE, PRINCIPAL OF APEX. "IT IS REALLY GRATIFYING WHEN WE SEE A CLIENT GROW FROM LITERALLY A GARAGE TO A WORLD CLASS COMPANY THAT CAN OFFER THEIR TECHNOLOGY TO A QUALITY COMPANY LIKE BECKMAN COULTER. WE ARE VERY PLEASE TO HAVE HAD THE OPPORTUNITY TO WORK WITH THE OWNERS AND EMPLOYEES TO GUIDE THEIR GROWTH AND HELP THEM NAVIGATE TO THIS VERY SUCCESSFUL CONCLUSION", CONTINUED DOYLE. "WE ARE HAPPY TO SEE THEIR HARD WORK AND SACRIFICE PAY OFF. THIS IS THE CLASSIC ENTREPRENEURIAL SUCCESS STORY, AND ONE WE SEE WITH OUR CLIENTS AROUND THE WORLD AS MORE ESTABLISHED COMPANIES LOOK TO INVENTIVE SHOPS LIKE NPE AND BLUE OCEAN FOR INNOVATION AND NEW PRODUCTS."

NPE AND BLUE OCEAN DEVELOPED AN INTEGRATED BLOOD TESTING SYSTEM THAT WILL BE SMALLER, LESS COSTLY AND MUCH MORE AUTOMATED THAN THOSE CURRENTLY FOUND IN HOSPITAL TEST FACILITIES OR OUTSIDE REFERENCE LABS. THESE NEW SYSTEMS REDUCE THE LABOR FACTOR, INCREASE THROUGHPUT AND GENERALLY MEET THE NEEDS OF THE CLINICAL AND RESEARCH INDUSTRIES, ACCORDING TO DOYLE. FLOW CYTOMETRY USED TO TEST FOR DISEASE, MONITOR MEDICATION LEVELS IN BLOOD AND CHARACTERIZE TISSUE BIOPSIES. BY MAKING THE TESTING SYSTEM SMALLER AND EASIER TO USE, NPE AND BLUE OCEAN HAVE ENABLED BOTH BIG MEDICAL CENTERS AND PHYSICIANS OFFICES TO OBTAIN TEST RESULTS MORE EFFICIENTLY AND IN A SHORT TIME.

ABOUT APEX BIOSTRATEGISTS: APEX IS AN ESTABLISHED ADVISORY FIRM SPECIALIZING IN ASSISTING SMALL COMPANIES, THEIR MANAGEMENT AND INVESTORS TO REACH THEIR GOALS. THE APEX TEAM CONSISTS OF EXPERIENCED BUSINESS EXECUTIVES, SUCCESSFUL ENTREPRENEURS AND PROFESSIONALS WHO HAVE YEARS OF PRACTICAL AND PROFESSIONAL EXPERIENCE AND EXTENSIVE NETWORKS AROUND THE WORLD TO BENEFIT THEIR CLIENTS. AT APEX, WE SOLVE PROBLEMS AND HELP OUR CLIENTS ACHIEVE THEIR GOALS INCLUDING VALUE OPTIMIZATION, SUCCESSFUL INVESTMENT EXIT, TECHNOLOGY LICENSES, STRATEGIC PLANS AND SITUATIONAL ASSESSMENT.

FOR MORE INFORMATION, PLEASE SEE WWW.APEXBIOSTRAT.COM OR EMAIL:INFO@APEXBIOSTRAT.COM

CONTACT:
MARTIN DOYLE
305-206-1513
MDOYLE@APEXBIOSTRAT.COM

Media Contact:

Martin Doyle Apex BioStrategists, 305-206-1513, med9344@aol.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Apex BioStrategists


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES